decrease font size
increase font size
change type face
bookmark this page
email this page
print this page
TheDairySite Latest News
Wednesday, July 16, 2008
Dutch Boycott UK Cattle Over TB Sale NETHERLANDS - The Dutch farmer organisation LTO is calling for a ban on British calf exports after 12 British calves, infected with bovine tuberculosis, were sold to The Netherlands.
Wednesday, April 30, 2008
Bluetongue Vaccine Release Outlines Strength of Intervet/SPAH Combination NETHERLANDS - Intervet/Schering-Plough Animal Health has released the first batch of Bovilis BTV8 vaccine against bluetongue to supply in Northern Europe.
Monday, April 21, 2008
Dairy Cooperatives to Merge NETHERLANDS - Two large dairy co-operatives in the Netherlands, Campina and Friesland Foods, have announced their intention to merge.
Thursday, February 28, 2008
Dutch Attack Bluetongue Finance Package The Dutch Agriculture Minister Gerda Verburg has hit out at the proposed financing of the European vaccination programme to fight bluetongue.
Thursday, January 17, 2008
Dutch Minister Calls for Sustainable Production Dutch Agriculture Minister Gerda Verburg has called for a 15 year sustainable cattle breeding programme.
Wednesday, January 16, 2008
Intervet Has Developed Bluetongue Vaccine THE NETHERLANDS – Animal health company Intervet International bv, part of Schering-Plough Corporation, has developed a vaccine against Bluetongue serotype 8, for sheep and cattle. The vaccine has been taken into production now. Intervet is aiming to...
Tuesday, July 03, 2007
Intervet opens new FMD vaccine facility BOXMEER – Today, Intervet, largest vaccine producer world wide, opens a new formulation and filling unit at the Foot and Mouth Disease (FMD) vaccine factory in Cologne, Germany. With this factory Intervet substantially strengthens its worldwide position...
Tuesday, March 13, 2007
Intervet bought by Schering-Plough NETHERLANDS - American based company Schering-Plough has announced it is to acquire the Dutch veterinary company Intervet as part of its buy out of Organon BioSciences, the pharmaceutical division of chemical company Akzo Nobel.








